Sept 27 (Reuters) - Merck & Co is in advanced talks to acquire drugmaker Acceleron Pharma Inc , the Wall Street Journal reported on Monday, citing people familiar with the matter.
A Bloomberg report last week said Acceleron was in talks to be acquired for more than $11 billion.
(Reporting by Uday Sampath in Bengaluru; Editing by Shinjini Ganguli)
精彩评论